RanavirusesV ertebrate antiviral immunity relies heavily on the interferon (IFN) response, which in mammals is comprised of three classes of cytokines, type I, II, and III IFNs (1). IFN-␥, the only mammalian type II IFN (bony fish possess multiple type II IFNs [2]) has a plethora of immune and antiviral roles, whereas type I and III IFNs function predominantly as antiviral molecules. While type I IFNs affect a broad range of cell types, the type III IFNs (also known as and IL-29) act on a limited range of cell subsets (3, 4). These differences are dictated at the receptor level, where the type I IFN receptors, IFNAR1 and IFNAR2, are ubiquitously expressed (5). In contrast, the type III receptor complex consists of the ligand-binding and IFN--specific IFNLR1 chain (interferon lambda receptor 1), which is expressed on a select subset of cells (chiefly among these are epithelial cells [6]), and the cell-signal propagating IL-10R2 chain (shared with IL-10, 8). Despite these differences, type I and type III IFN cytokines utilize the same downstream signaling pathways, culminating in comparable antiviral outcomes, including increased gene expression of antiviral cellular mediators such as protein kinase R (PKR) and myxovirus resistance (Mx) proteins (1).While the mammalian IFN responses have been relatively well characterized, the IFN immunity of phylogenetically more ancestral ectothermic vertebrate species appears to be distinct. At present, only the type I IFN systems of bony fish have been explored in detail, and it is thought that teleosts do not possess type III IFNs. The fish type I IFNs are subdivided into four groups (IFNa to IFNd) according to phylogeny (9, 10), and unlike the single cognate type I IFN receptor complex of mammals (11, 12), fish group I and II IFNs signal through distinct receptor complexes (13). We have recently demonstrated that the amphibian Xenopus laevis